BOSTON (Reuters) - New ultra-sensitive blood tests can rapidly detect when heart muscle is dying from a heart attack, even from the moment the patient arrives in the emergency room, according to two ...
Background and Goal: Chest pain is a common but challenging symptom for general practitioners to evaluate, as it can be caused by both serious conditions and more benign issues. This study assessed ...
We undertook an international prospective cohort study involving patients 18 years of age or older who underwent cardiac surgery. High-sensitivity cardiac troponin I measurements (upper reference ...
A study published in the European Heart Journal could help predict the likelihood of dementia up to 25 years in advance. The research found a link between increased levels of cardiac troponin, a ...
TARRYTOWN, N.Y.--(BUSINESS WIRE)--A new prognosis claim for the Siemens Healthineers Atellica IM High-Sensitivity Troponin I (TnIH) test 1 immediately advances care for at-risk cardiac patients in the ...
ANAHEIM, Calif., Nov. 14 – A blood test that detects elevated protein levels associated with dying heart cells could dramatically increase the number of individuals with chest pain who are diagnosed ...
In an unselected group of patients who underwent a blood test at a hospital for any reason, an elevated cardiac troponin I concentration was associated with a higher mortality risk through more than 2 ...
If done with the right preparations, hospital systems can make the switch to high-sensitivity cardiac troponin (hs-cTn) assays for the evaluation of chest pain in the emergency department (ED) without ...
Switching from a conventional to a high-sensitivity cardiac troponin I assay in emergency departments is associated with a reduction in both mortality at 1 year and new admissions for myocardial ...
A simple £5 blood test for the protein troponin could predict a person's risk of heart attacks and strokes with greater accuracy than ever before, research suggests. Troponin is found in heart muscle ...
Certain blood tests have been recalled due to risk for false negative or falsely low cardiac troponin levels. The FDA designated the recall as serious due to the risks of a missed or delayed MI ...